Trial
NCT03417739
A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Dana-Farber Cancer Institute
Collaborators
BioMed Valley Discoveries, Inc
Condition
Uveal Melanoma
Intervention
BVD-523
Why stopped
This was a Simon two stage design trial that terminated after the first stage due to lack of response.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-25